Vancomycin-resistant enterococci: Clinical, microbiologic, and epidemiologic features

Journal of Laboratory and Clinical Medicine

Volumn 130, Issue 1, 1997, Pages 14-20

  Noskin, Gary A ^a  

^a NORTHWESTERN UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 0031193463     PISSN: 00222143     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0022-2143(97)90054-8     Document Type: Review

References (40)

1. Schaberg DR, Culver DH, Gaynes RP. Major trends in the microbial etiology of nosocomial infections. Am J Med 1991;91(suppl 3B):73S-5S.
2. Moellering RC. Emergence of enterococcus as a significant pathogen. Clin Infect Dis 1992;14:1173-8.
3. Murray BE. The life and the times of the enterococcus. Clin Microbiol Rev 1990;3:46-65.
4. Leclercq R, Derlot E, Duval J, Courvalin P. Plasmid-mediated resistance to vancomycin and teicoplanin in Enterococcus faecium. N Eng J Med 1988;319:157-61.
5. Rubin LG, Tucci V, Cercenado E, Eliopoulos G, Isenberg HD. Vancomycin-resistant Enterococcus faecium in hospitalized children. Infect Control Hosp Epidemiol 1992;13:700-5.
6. Karanfil LV, Murphy M, Josephson A, Gaynes R, Mandel L, Hill BC, et al. A cluster of vancomycin-resistant Enterococcus faecium in an intensive care unit. Infect Control Hosp Epidemiol 1992;13:195-200.
7. Frieden TR, Munsiff SS, Low DE, et al. Emergence of vancomycin-resistant enterococci in New York City. Lancet 1993;342:76-9.
8. Boyle JF, Soumakis SA, Rendo A, et al. Epidemiologic analysis and genotypic characterization of a nosocomial outbreak of vancomycin-resistant enterococci. J Clin Microbiol 1993;31:1280-5.
9. Montecalvo MA, Horowitz H, Gedris C, et al. Outbreak of vancomycin-, ampicillin-, and aminoglycoside-resistant Enterococcus faecium bacteremia in an adult oncology unit. Antimicrob Agents Chemother 1994;38:1363-7.
10. Handwerger S, Raucher B, Altarac D, et al. Nosocomial outbreak due to Enterococcus faecium highly resistant to vancomycin, penicillin, and gentamicin. Clin Infect Dis 1992;16:750-5.
11. Uttley AHC, Woodford N, Johnson AP, Cookson B, George RC. Vancomycin-resistant enterococci. Lancet 1993;342:615.
12. Handwerger S, Perlman DC, Altarac D, McAuliffe V. Concomitant high-level vancomycin and penicillin resistance in clinical isolates of enterococci. Clin Infect Dis 1992;14:655-66.
13. Wade J, Rolando N, Casewell M. Resistance of Enterococcus faecium to vancomycin and teicoplanin. Lancet 1991;337:1616.
14. Edmond MB, Ober JF, Weinbaum DL, et al. Vancomycinresistant Enterococcus faecium bacteremia: risk factors for infection. Clin Infect Dis 1995;20:1126-33.
15. Noskin GA, Peterson LR, Warren JR. Enterococcus faecium and Enterococcus faecalis bacteremia: acquisition and outcome. Clin Infect Dis 1995;20:296-301.
16. Livornese LL, Dias S, Samuel C, Romanowski B, Taylor S, May P, et al. Hospital-acquired infection with vancomycin-resistant Enterococcus faecium transmitted by electronic thermometers. Ann Intern Med 1992;117:112-6.
17. Pouedras P, Leclercq R, Donnio PY, Sire JM, Mesnard R, Avril JL. Bacteremia due to vancomycin-resistant Enterococcus faecium of Van B phenotype during prophylaxis with vancomycin. Clin Infect Dis 1992;15:752-3.
18. Boyce JM, Opal SM, Chow JW, et al. Outbreak of multidrug-resistant Ebterococcus faecium with transferable vanB class vancomycin resistance. J Clin Microbiol 1994;32:1148-53.
19. Zervos MJ, Bacon AE, Patterson JE, Schaberg DR, Kauffman CA. Enterococcal superinfection in patients treated with ciprofloxacin. J Antimicrob Chemother 1988;21:113-5.
20. Stosor V, Postelnick M, Peterson LR, Noskin GA. Enterococcus faecium bacteremia: does vancomycin resistance make a difference? Arch Intern Med (in press).
21. Noskin GA, Stosor V, Cooper I, Peterson LR. Recovery of vancomycin resistant enterococci on fingertips and environmental surfaces. Infect Control Hosp Epidemiol 1995;16:577-81.
22. Tenover FC, Tokars J, Swenson J, Paul S, Spitalny K, Jarvis W. Ability of clinical laboratories to detect antimicrobial agent-resistant enterococci. J Clin Microbiol 1993;31:1695-9.
23. Snell JJ, Brown DFJ, Perry SF, George R. Antimicrobial susceptibility testing of enterococci: results of a survey conducted by the United Kingdom National External Quality Assessment Scheme for Microbiology. J Antimicrob Chemother 1993;32:401-11.
24. Fraimow HS, Venuti E. Inconistent bactericidal activity of triple-combination therapy with vancomycin, ampicillin, and gentamicin against vancomycin-resistant, highly ampicillin-resistant Enterococcus faecium. Antimicrob Agents Chemother 1992;36:1563-6.
25. Unal S, Flokowitsch J, Mullen DL, Preston DA, Nicas TI. In-vitro synergy and mechansim of interaction between vancomycin and ciprofloxacin against enterococcal isolates. J Antimicrob Chemother 1993;31:711-23.
26. Sader HS, Pfaller MA, Tenover FC, Hollis RJ, Jones RN. Evaluation and characterization of multiresistant Enterococcus faecium from 12 U.S. medical centers. J Clin Microbiol 1994;32:2840-2.
27. Landman D, Mobaraki NK, Quale JM. Novel antibiotic regimens against Enterococcus faecium resistant to ampicillin, vancomycin, and gentamicin. Antimicrob Agents Chemother 1993;37:1904-8.
28. Whitman MS, Pitsakis PG, Zausner A, et al. Anitbiotic treatment of experimental endocarditis due to vancomycin-and ampicillin-resistant Enterococcus faecium. Antimicrob Agents Chemother 1993;37:2069-73.
29. Quale JM, Landman D, Mobaraki N. Treatment of experimental endocarditis due to multidrug resistant Enterococcus faecium with ciprofloxacin and novobiocin. J Antimicrob Chemother 1994;34:797-802.
30. Caron F, Lemeland JF, Humbert G, Klare I, Gutmann L. Triple combination penicillin-vancomycin-gentamicin for experimental endocarditis caused by a highly penicillin- and glycopeptide-resistant isolate of Enterococcus faecium. J Infect Dis 1993;168:681-6.
31. Caron F, Pestel M, Kitzis MD, Lemeland JF, Humbert GF, Gutmann L. Comparison of different β-lactam-glycopeptide-gentamicin combinations for an experimental endocarditis caused by a highly glycopeptide-resistant isolate of Enterococcus faecium. J Infect Dis 1994;171:106-12.
32. Norris AH, Reilly JP, Edelstein PH, Brennan PJ, Schuster MG. Chloramphenicol for the treatment of vancomycin-resistant enterococcal infections. Clin Infect Dis 1995;20:1137-44.
33. Hospital Infection Control Practices Advisory Committee. Recommendations for preventing the spread of vancomycin resistance. Infect Control Hosp Epidemiol 1995;16:105-13.
34. Slaughter S, Hayden MK, Nathan C, et al. A comparison of the effect of universal use of gloves and gowns with that of glove use alone on acquisition of vancomycin-resstant enterococci in a medical intensive care unit. Ann Intern Med 1996;215:448-56.
35. Ena J, Dick RW, Jones RN, Wenzel RP. The epidemiology of intravenous vancomycin usage in a university hospital: a 10-year study. JAMA 1993;269:598-602.
36. Quale J, Landman D, Saurina G, Atwood E, DiTore V, Patel K. Manipulation of a hospital antimicrobial formulary to control an outbreak of vancomycin-resistant enterococci. Clin Infect Dis 1996;23:1020-5.
37. Noskin GA, Postelnick M, Peterson LR. Control of enterococci by restriction of third generation cephalosporins. In: Abstracts of the Thirty-second Annual Meeting of the Infectious Diseases Society of America. Clin Infect Dis 1994;19:597.
38. Noskin GA, Cooper I, Peterson LR. Vancomycin resistant Enterococcus faecium sepsis following persistent colonization. Arch Intern Med 1995;155:1445-7.
39. Van der Auwera P, Pensart N, Korten V, Murray BE, Leclercq R. Influence of oral glycopeptides on the fecal flora of human volunteers: selection of highly glycopeptide-resistant enterococci. J Infect Dis 1996:173:1129-36.
40. Coque TM, Tomayko JF, Ricke SC, Okhyusen PC, Murray BE. Vancomycin-resistant enterococci from nosocomial, community, and animal sources in the United States. Antimicrob Agents Chemother 1996;40:2605-9.